Literature DB >> 11294893

A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

R S Stewart1, B Drisaldi, D A Harris.   

Abstract

Although there is considerable evidence that PrP(Sc) is the infectious form of the prion protein, it has recently been proposed that a transmembrane variant called (Ctm)PrP is the direct cause of prion-associated neurodegeneration. We report here, using a mutant form of PrP that is synthesized exclusively with the (Ctm)PrP topology, that (Ctm)PrP is retained in the endoplasmic reticulum and is degraded by the proteasome. We also demonstrate that (Ctm)PrP contains an uncleaved, N-terminal signal peptide as well as a C-terminal glycolipid anchor. These results provide insight into general mechanisms that control the topology of membrane proteins during their synthesis in the endoplasmic reticulum, and they also suggest possible cellular pathways by which (Ctm)PrP may cause disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294893      PMCID: PMC32273          DOI: 10.1091/mbc.12.4.881

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  33 in total

Review 1.  Setting the standards: quality control in the secretory pathway.

Authors:  L Ellgaard; M Molinari; A Helenius
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Unusual topogenic sequence directs prion protein biogenesis.

Authors:  C D Lopez; C S Yost; S B Prusiner; R M Myers; V R Lingappa
Journal:  Science       Date:  1990-04-13       Impact factor: 47.728

3.  Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein.

Authors:  C S Yost; C D Lopez; S B Prusiner; R M Myers; V R Lingappa
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

4.  Control of topology and mode of assembly of a polytopic membrane protein by positively charged residues.

Authors:  G von Heijne
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

5.  A calcium-dependent antibody for identification and purification of recombinant proteins.

Authors:  K S Prickett; D C Amberg; T P Hopp
Journal:  Biotechniques       Date:  1989-06       Impact factor: 1.993

6.  Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein [published errratum appears in Mol Cell Biol 1987 May;7(5):2035].

Authors:  B Hay; R A Barry; I Lieberburg; S B Prusiner; V R Lingappa
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

7.  Evidence for a secretory form of the cellular prion protein.

Authors:  B Hay; S B Prusiner; V R Lingappa
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

8.  Most pathogenic mutations do not alter the membrane topology of the prion protein.

Authors:  R S Stewart; D A Harris
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

9.  Molecular location of a species-specific epitope on the hamster scrapie agent protein.

Authors:  D C Bolton; S J Seligman; G Bablanian; D Windsor; L J Scala; K S Kim; C M Chen; R J Kascsak; P E Bendheim
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

10.  Glycosylation can influence topogenesis of membrane proteins and reveals dynamic reorientation of nascent polypeptides within the translocon.

Authors:  V Goder; C Bieri; M Spiess
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  35 in total

1.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.

Authors:  J Ma; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

2.  Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.

Authors:  Y Yedidia; L Horonchik; S Tzaban; A Yanai; A Taraboulos
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

3.  Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Authors:  Soo Jung Kim; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

Review 4.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

5.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

6.  Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane.

Authors:  Matloob Husain; Andrea S Weisberg; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

7.  Cell-specific metabolism and pathogenesis of transmembrane prion protein.

Authors:  Yaping Gu; Xiu Luo; Subhabrata Basu; Hisashi Fujioka; Neena Singh
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Alternative translation initiation generates cytoplasmic sheep prion protein.

Authors:  Christoffer Lund; Christel M Olsen; Susan Skogtvedt; Heidi Tveit; Kristian Prydz; Michael A Tranulis
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

9.  The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein.

Authors:  Mauricio Torres; Danilo B Medinas; José Manuel Matamala; Ute Woehlbier; Víctor Hugo Cornejo; Tatiana Solda; Catherine Andreu; Pablo Rozas; Soledad Matus; Natalia Muñoz; Carmen Vergara; Luis Cartier; Claudio Soto; Maurizio Molinari; Claudio Hetz
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

10.  Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Authors:  Max Nunziante; Kerstin Ackermann; Kim Dietrich; Hanna Wolf; Lars Gädtke; Sabine Gilch; Ina Vorberg; Martin Groschup; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.